IP Library Granted Patent US 11,970,520
Granted Patent B2
US 11,970,520 · App. 17/578,690 · Granted Apr 30, 2024

Alpha-synuclein substrates and methods for making and using the same

Inventors: Luis Concha (San Diego, CA); Carly Farris (San Diego, CA); Bret Holguin (San Diego, CA); Yihua Ma (Corona, CA)
Assignee: Amprion, Inc.
C07K14/47B01L3/5027C07K1/34C12N1/06C12N15/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,970,520
App. No.
17/578,690
Granted
Apr 30, 2024
Kind
B2
Abstract

An expression vector is provided for production of human alpha-synuclein (αS) protein or a conservative variant thereof that exhibits a decreased tendency to self-aggregate in an αS seed amplification assay (SAA). The expression vector comprises a nucleic acid sequence coding for human αS protein or a conservative variant, the nucleic acid sequence comprising codons that have been optimized to produce human αS protein or a conservative variant when expressed by a host cell such as E. coli . The codons have been optimized to avoid amino acid misincorporation in the expressed protein. Methods for purification of the expressed protein are also provided.

Claims (14)

1. A nucleic acid comprising a sequence having at least 95% identity with SEQ ID NO: 1, wherein the nucleic acid sequence encodes for a protein of the sequence of SEQ ID NO: 6 when expressed in an enterobacterial host cell.

2. An expression vector comprising the nucleic acid sequence of claim 1 .

3. The nucleic acid of claim 1 , wherein the nucleic acid sequence is incorporated into an expression vector to comprise a nucleic acid sequence having at least 95% identity with SEQ ID NO: 2.

4. A composition comprising a protein consisting of SEQ ID NO: 6.

5. A method for preparing a protein of the sequence of SEQ ID NO: 6, the method comprising:

introducing into an enterobacterial host cell a nucleic acid comprising a sequence comprising at least 95% identity with SEQ ID NO: 1;

culturing the enterobacterial host cell under conditions effective to produce the protein; and

obtaining the protein from the enterobacterial host cell.

6. The method of claim 5 , wherein the nucleic acid sequence is incorporated into an expression vector to comprise a nucleic acid sequence having at least 95% identity with SEQ ID NO: 2.

7. The method of claim 5 , wherein the enterobacteria comprises Escherichia coli.

8. The method of claim 5 , wherein the method further comprises an acid precipitation step to purify the protein.

9. An enterobacterial host cell expressing the nucleic acid sequence of claim 1 .

10. A modified enterobacterial host cell, the modified enterobacterial host cell expressing a heterologous nucleic acid that encodes for a protein of the sequence of SEQ ID NO: 6.

11. The modified enterobacterial host cell of claim 10 , wherein the enterobacteria comprises Escherichia coli.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2022
From: CONCHA, LUIS; FARRIS, CARLY; HOLGUIN, BRET; MA, YIHUA
To: AMPRION, INC.
Reel/Frame 061508/0896 →
Continuity (10)
Continuation 17323919 · May 18, 2021
Continuation In Part 17011374 · Sep 3, 2020
Provisional Application 63073420 · Sep 1, 2020
Provisional Application 63073424 · Sep 1, 2020
Provisional Application 63045593 · Jun 29, 2020
Provisional Application 63042679 · Jun 23, 2020
Provisional Application 63040144 · Jun 17, 2020
Provisional Application 63026394 · May 18, 2020
Provisional Application 62895535 · Sep 4, 2019
Related Publication 20220135632A1 · May 5, 2022